Bibliography
- National Institutes of Health. NCATS. 2014. Available from: http://www.ncats.nih.gov/research/research.html [Accessed 12 March 2014]
- Orphan Drug Act, H.R. 5238, Public Law No. 97-414, 97th Congress, 1983
- Federal Register. Clinical studies of safety and effectiveness of orphan products research project grant (R01). 2012. Available from: https://www.federalregister.gov/articles/2012/08/06/2012-19086/clinical-studies-of-safety-and-effectiveness-of-orphan-products-research-project-grant-r01 [Accessed 25 March 2013]
- National Institutes of Health Guide for Grants and Contracts. Funding opportunities and notices. 2012. Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-13-001.html [Last accessed 25 March 2013]
- Milne CP, Tait J. Evolution along the government-governance continuum: FDA’sorphan products and fast track programs as exemplars of what works for innovation and regulation. Food & Drug L J 2009;64:733-53
- Institute of Medicine (IOM). Rare diseases and orphan products: accelerating research and development. The National Academies Press, Washington DC; 2010
- Bureau of Labor and Statistics. Consumer Price Index. 2012. Available from: http://www.bls.gov/cpi/ [Accessed 25 March 2013]
- Kaitin KI, DiMasi JA. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000–2009. Clinical Pharm Ther 2011;89:183-8
- Haffner ME. Developing treatments for inborn errors: incentives available to the clinician. Mol Genet Metab 2004;81:S63-6
- Yin W. Market incentives and pharmaceutical innovation. J Health Econ 2008;27:1060-77
- Coté T, Kelkar A, Xu K, et al. Orphan products: an emerging trend in drug approvals. Nat Rev Drug Discov 2010;9:84
- Haffner M, Maher P. The impact of the orphan drug act on drug discovery. Expert Opin Drug Discov 2006;1:521-4
- Haffner ME, Whitley J, Moses M. Two decades of orphan product development. Nat Rev Drug Discov 2002;1:821-5
- Hughes DA, Tunnage B, Yeo ST. Drugs for exceptionally rare diseases: do they deserve special status for funding? QJM 2005;98:829-36
- National Institutes of Health. National Center for Advancing Translational Sciences. Therapeutics for Rare and Neglected Diseases. 2012. Available from: http://www.ncats.nih.gov/research/rare-diseases/trnd/trnd.html [Last accessed 25 March 2013]
- International Rare Diseases Research Consortium (IRDiRC). 2011. Available from: http://ec.europa.eu/research/health/medical-research/rare-diseases/index_en.html [Accessed 25 March 2013]